A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma
Clinical trial NCT03138811 · COMPLETED
Trial details
- NCT number
- NCT03138811
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2019-07-16
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.